Cell and Tissue Culture Supplies

Cell and Tissue Culture Supplies

Global Cell and Tissue Culture Supplies Market to Reach US$42.5 Billion by 2030

The global market for Cell and Tissue Culture Supplies estimated at US$22.3 Billion in the year 2023, is expected to reach US$42.5 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2023-2030. Cell and Tissue Culture Consumables, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$24.0 Billion by the end of the analysis period. Growth in the Cell and Tissue Culture Equipment segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.0 Billion While China is Forecast to Grow at 13.7% CAGR

The Cell and Tissue Culture Supplies market in the U.S. is estimated at US$6.0 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.5 Billion by the year 2030 trailing a CAGR of 13.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Cell and Tissue Culture Supplies  - Key Trends and Drivers

Cell culture technology, fundamental in biological and medical research, is witnessing significant growth driven by advances in biotechnology and increased demand for biopharmaceuticals, regenerative medicine, and clinical research. The industry`s future is promising, with trends like automation, customization, and a focus on safety and ethics shaping its trajectory. These trends suggest a continued evolution in cell and tissue culture technology, with implications for medicine, research, and biotechnology globally.

Advancements in cell and tissue culture technologies are reshaping drug development and testing, offering more physiologically relevant and predictive models. Innovations such as 3D cell culture and organ-on-a-chip technologies promise safer, more effective treatments and more efficient drug development processes. As the industry progresses, these technologies are expected to play a central role in the next wave of pharmaceutical innovation.

Key market growth drivers include the expansion of biopharmaceuticals, advances in regenerative medicine, and technological innovations in cell culture techniques. There`s a growing demand for specialized culture supplies to support the production of biologics and the development of regenerative medicine therapies. Technological advancements, such as 3D cell culture and organ-on-a-chip devices, offer more accurate disease modeling and drug screening capabilities, reducing reliance on animal testing and improving laboratory results` reliability. Additionally, there`s a shift towards synthetic and specialty media solutions and increased automation in cell culture processes to enhance productivity and reproducibility. As the scale of cell culture operations grows, especially in industrial biotech and pharmaceutical settings, there is an increasing reliance on automation. Automated cell culture systems and bioreactors reduce the need for manual intervention, improve the reproducibility of experiments, and increase throughput. This trend is driving demand for compatible supplies and equipment that can integrate with automated workflows.

 

Select Competitors (Total 73 Featured) -

• Avantor, Inc.
• BD Biosciences
• BioIVT
• Cell Culture Technologies
• Corning Inc.
• GE Healthcare Life Sciences
• Irvine Scientific Inc.
• Lonza Group AG
• Merck Millipore GmbH
• MP Biomedicals LLC
• ORIGIO a/s
• PromoCell GmbH
• Sigma-Aldrich Corporation
• Thermo Fischer Scientific Inc.
• Vitrolife AB

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.